Incorporating genetic testing and counseling for prostate cancer into clinical practice

“I think this is an area that needs to be really personalized to each clinical practice,” says Alicia K. Morgans, MD, MPH.

In this video, Alicia K. Morgans, MD, MPH, discusses the practices she implements regarding germline and somatic testing in patients with advanced prostate cancer. These ideas were focused on in her presentation, “Advanced disease: incorporating molecular markers and genomic studies into therapy,” presented recently at the 2021 Society of Urologic Oncology Annual Meeting. Morgans is a genitourinary medical oncologist and medical director of the Survivorship Program at the Dana-Farber Cancer Institute in Boston, Massachusetts.